Antipsychotics & diabetes 1 October 2013 People who take atypical antipsychotics have an increased risk of developing diabetes. Atypical antipsychotics are usually used to treat schizophrenia, bipolar disorder, dementia, anxiety disorder, Austism Spectrum Disorder and obsessive-compulsive disorder. If you already have diabetes, you have an increased risk of developing hyperglycaemia (high blood glucose levels outside target range) when starting antipsychotics. While it is not clear why atypical antipsychotics affect blood glucose levels, it is believed that these medications stop the brain from sensing when the body has had enough to eat, leading to weight gain and insulin resistance. If you are taking atypical antipsychotics and experiencing blood glucose levels higher than the recommended target, you should NOT stop taking your medication. Instead, it is important that you discuss this with your GP, endocrinologist, physician or psychiatrist. For more information contact: Your state based diabetes organisation infoline on 1800 637 700 Beyond Blue
Media releases 25 May 2026 New partnership on Target to deliver health checks New data from self-serve health check stations reveals as many as one in three Queenslanders could have risk factors that they should discuss with their health professional. Continue Reading
Media releases 13 May 2026 Momentum builds following government response to diabetes inquiry The diabetes sector has welcomed the Federal Government’s response to the Parliamentary Inquiry into Diabetes, which provides in-principle support for... Continue Reading
Media releases 9 May 2026 Research reveals genes may determine who benefits most from popular weight-loss and diabetes medicines New research supported by Diabetes Australia has confirmed that a person’s genes can influence how well widely used diabetes medicines... Continue Reading